Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4-10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD Score

scientific article

Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4-10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD Score is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2015/596797
P932PMC publication ID4628742
P698PubMed publication ID26557679
P5875ResearchGate publication ID283717140

P2093author name stringRui Wang
Wei Yu
Zhongcheng Xin
Xiaoying Wang
Xuesong Li
Qun He
Dong Fang
Liqun Zhou
Huihui Wang
Chenglin Zhao
Chenguang Xi
Da Ren
P2860cites workPercent free prostate specific antigen does not enhance the specificity of total prostate specific antigen for the detection of prostate cancer in Korean men 50 to 65 years old: a prospective multicenter studyQ57211837
Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detectionQ63966218
Using gray-scale and color and power Doppler sonography to detect prostatic cancerQ73508272
Mortality results from a randomized prostate-cancer screening trialQ24601536
ESUR prostate MR guidelines 2012Q24620926
The role of magnetic resonance imaging in the diagnosis and management of prostate cancerQ26849794
Screening and prostate-cancer mortality in a randomized European studyQ29617485
Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers.Q30705187
Early detection of prostate cancer: AUA GuidelineQ33608474
Prostate-specific antigen levels in the United States: implications of various definitions for abnormalQ33989110
Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detectionQ34015600
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trialQ34469941
MRI-ultrasound fusion for guidance of targeted prostate biopsyQ34645142
Annual report on status of cancer in China, 2011Q35085507
Longitudinal trends in prostate cancer incidence, mortality, and survival of patients from two Shanghai city districts: a retrospective population-based cohort study, 2000-2009.Q35147324
Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.Q35495406
Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR ImagingQ35670525
Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancerQ37254919
Uptake of prostate cancer screening and associated factors among Chinese men aged 50 or more: a population-based survey.Q37672443
Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds.Q37937948
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.Q38160994
MR imaging of the prostateQ38216958
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigenQ39716047
Development and external validation of an extended 10-core biopsy nomogramQ39770203
Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.Q39845544
Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical informationQ39988569
Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy.Q40004173
Nomogram using transrectal ultrasound-derived information predicting the detection of high grade prostate cancer on initial biopsyQ40149911
Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population?Q40255038
P275copyright licenseCreative Commons Attribution 3.0 UnportedQ14947546
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P304page(s)596797
P577publication date2015-10-18
P1433published inBioMed Research InternationalQ17509958
P1476titlePrevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4-10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD Score
P478volume2015

Reverse relations

Q36265470Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zonecites workP2860

Search more.